Top

Published in:

25-07-2023 | Renal Infarction | Art in the Ward

Paradoxical renal embolization via patent foramen ovale: a case of complicated pulmonary embolism and renal infarction mitigated by accessory renal arteries (Nephrology images)

Authors: Gabriel Stefan, Ana-Maria Badea, Dan Spataru, Simona Stancu

Published in: Journal of Nephrology | Issue 9/2023

Excerpt

A 50-year-old male, known to have diabetes mellitus, presented to the emergency department with acute dyspnea. His past medical history was notable for symptoms suggestive of deep vein thrombosis in his right lower leg one month prior (the patient did not seek medical evaluation at that time). He was diagnosed with pulmonary embolism in our service, likely secondary to untreated deep vein thrombosis. Transthoracic echocardiography detected right ventricular systolic dysfunction and a patent foramen ovale with a floating thrombus through the interatrial defect between the right and left atrium. …

Windecker S, Stortecky S, Meier B (2014) Paradoxical embolism. J Am Coll Cardiol 64(4):403–415. https://doi.org/10.1016/j.jacc.2014.04.063CrossRef

Iizuka Y, Tsuchida T, Ashikaga K, Ie K, Matsuda T, Ishizuka K, Okuse C, Matsuda T, Ohira Y (2023) Patent foramen ovale complicated with renal infarction and pulmonary embolism: a case report with literature review. Cureus 15(2):e35433. https://doi.org/10.7759/cureus.35433CrossRefPubMedPubMedCentral

Title: Paradoxical renal embolization via patent foramen ovale: a case of complicated pulmonary embolism and renal infarction mitigated by accessory renal arteries (Nephrology images)
Authors: Gabriel Stefan
Ana-Maria Badea
Dan Spataru
Simona Stancu
Publication date: 25-07-2023
Publisher: Springer International Publishing
Keywords: Renal Infarction
Transthoracic Echocardiography
Phlebothrombosis
Published in: Journal of Nephrology / Issue 9/2023
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-023-01722-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2023

Impact of ABO incompatibility and early antibody-mediated rejection on chronic antibody-mediated rejection in kidney transplant patients

Cystinuria without cystine? Correct assessment to avoid misdiagnosis: lessons for the clinical nephrologist

At least one hyperkalemia episode is associated with mortality and disease progression in stage 3 CKD patients

Urine-to-plasma creatinine ratio and fractional excretion of urea performance in acute-on-chronic kidney disease patients

Prevalence and clinical association of hyperechoic crystal deposits on ultrasonography in patients with chronic kidney disease: a cross-sectional study from a single center

Impact of thrice-weekly cotrimoxazole prophylaxis on creatinine and potassium plasma levels in kidney transplant recipients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials